United States Bevacizumab Market Report 2016

Market: Pharma & Healthcare

, 101 pages report, published by QYResearch

Report ThumbnailDecember-2016
Notes:
Sales, means the sales volume of Bevacizumab
Revenue, means the sales value of Bevacizumab

This report studies sales (consumption) of Bevacizumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Biocon
Bionomics
Amgen
Genexine
Levolta Pharmaceuticals
Enzon Pharmaceuticals
Marsala Biotech
Mabtech
Fujifilm Kyowa Kirin Biologics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Bevacizumab in each application, can be divided into
Application 1
Application 2
Application 3

  • List of Tables and Figures
  • Figure Picture of Bevacizumab
  • Table Classification of Bevacizumab
  • Figure United States Sales Market Share of Bevacizumab by Type in 2015
  • Table Application of Bevacizumab
  • Figure United States Sales Market Share of Bevacizumab by Application in 2015
  • Figure United States Bevacizumab Sales and Growth Rate (2011-2021)
  • Figure United States Bevacizumab Revenue and Growth Rate (2011-2021)
  • Table United States Bevacizumab Sales of Key Manufacturers (2015 and 2016)
  • Table United States Bevacizumab Sales Share by Manufacturers (2015 and 2016)
  • Figure 2015 Bevacizumab Sales Share by Manufacturers
  • Figure 2016 Bevacizumab Sales Share by Manufacturers
  • Table United States Bevacizumab Revenue by Manufacturers (2015 and 2016)
  • Table United States Bevacizumab Revenue Share by Manufacturers (2015 and 2016)
  • Table 2015 United States Bevacizumab Revenue Share by Manufacturers
  • Table 2016 United States Bevacizumab Revenue Share by Manufacturers
  • Table United States Market Bevacizumab Average Price of Key Manufacturers (2015 and 2016)
  • Figure United States Market Bevacizumab Average Price of Key Manufacturers in 2015
  • Figure Bevacizumab Market Share of Top 3 Manufacturers
  • Figure Bevacizumab Market Share of Top 5 Manufacturers
  • Table United States Bevacizumab Sales by Type (2011-2016)
  • Table United States Bevacizumab Sales Share by Type (2011-2016)
  • Figure United States Bevacizumab Sales Market Share by Type in 2015
  • Table United States Bevacizumab Revenue and Market Share by Type (2011-2016)
  • Table United States Bevacizumab Revenue Share by Type (2011-2016)
  • Figure Revenue Market Share of Bevacizumab by Type (2011-2016)
  • Table United States Bevacizumab Price by Type (2011-2016)
  • Figure United States Bevacizumab Sales Growth Rate by Type (2011-2016)
  • Table United States Bevacizumab Sales by Application (2011-2016)
  • Table United States Bevacizumab Sales Market Share by Application (2011-2016)
  • Figure United States Bevacizumab Sales Market Share by Application in 2015
  • Table United States Bevacizumab Sales Growth Rate by Application (2011-2016)
  • Figure United States Bevacizumab Sales Growth Rate by Application (2011-2016)
  • Table Pfizer Basic Information List
  • Table Pfizer Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Figure Pfizer Bevacizumab Sales Market Share (2011-2016)
  • Table Biocon Basic Information List
  • Table Biocon Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Biocon Bevacizumab Sales Market Share (2011-2016)
  • Table Bionomics Basic Information List
  • Table Bionomics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Bionomics Bevacizumab Sales Market Share (2011-2016)
  • Table Amgen Basic Information List
  • Table Amgen Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Amgen Bevacizumab Sales Market Share (2011-2016)
  • Table Genexine Basic Information List
  • Table Genexine Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Genexine Bevacizumab Sales Market Share (2011-2016)
  • Table Levolta Pharmaceuticals Basic Information List
  • Table Levolta Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Levolta Pharmaceuticals Bevacizumab Sales Market Share (2011-2016)
  • Table Enzon Pharmaceuticals Basic Information List
  • Table Enzon Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Enzon Pharmaceuticals Bevacizumab Sales Market Share (2011-2016)
  • Table Marsala Biotech Basic Information List
  • Table Marsala Biotech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Marsala Biotech Bevacizumab Sales Market Share (2011-2016)
  • Table Mabtech Basic Information List
  • Table Mabtech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Mabtech Bevacizumab Sales Market Share (2011-2016)
  • Table Fujifilm Kyowa Kirin Biologics Basic Information List
  • Table Fujifilm Kyowa Kirin Biologics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Fujifilm Kyowa Kirin Biologics Bevacizumab Sales Market Share (2011-2016)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Bevacizumab
  • Figure Manufacturing Process Analysis of Bevacizumab
  • Figure Bevacizumab Industrial Chain Analysis
  • Table Raw Materials Sources of Bevacizumab Major Manufacturers in 2015
  • Table Major Buyers of Bevacizumab
  • Table Distributors/Traders List
  • Figure United States Bevacizumab Production and Growth Rate Forecast (2016-2021)
  • Figure United States Bevacizumab Revenue and Growth Rate Forecast (2016-2021)
  • Table United States Bevacizumab Production Forecast by Type (2016-2021)
  • Table United States Bevacizumab Consumption Forecast by Application (2016-2021)
  • Table of Contents
  • United States Bevacizumab Market Report 2016
  • 1 Bevacizumab Overview
  • 1.1 Product Overview and Scope of Bevacizumab
  • 1.2 Classification of Bevacizumab
  • 1.2.1 Type I
  • 1.2.2 Type II
  • 1.2.3 Type III
  • 1.3 Application of Bevacizumab
  • 1.3.1 Application 1
  • 1.3.2 Application 2
  • 1.3.3 Application 3
  • 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bevacizumab (2011-2021)
  • 1.4.1 United States Bevacizumab Sales and Growth Rate (2011-2021)
  • 1.4.2 United States Bevacizumab Revenue and Growth Rate (2011-2021)
  • 2 United States Bevacizumab Competition by Manufacturers
  • 2.1 United States Bevacizumab Sales and Market Share of Key Manufacturers (2015 and 2016)
  • 2.2 United States Bevacizumab Revenue and Share by Manufactures (2015 and 2016)
  • 2.3 United States Bevacizumab Average Price by Manufactures (2015 and 2016)
  • 2.4 Bevacizumab Market Competitive Situation and Trends
  • 2.4.1 Bevacizumab Market Concentration Rate
  • 2.4.2 Bevacizumab Market Share of Top 3 and Top 5 Manufacturers
  • 2.4.3 Mergers & Acquisitions, Expansion
  • 3 United States Bevacizumab Sales (Volume) and Revenue (Value) by Type (2011-2016)
  • 3.1 United States Bevacizumab Sales and Market Share by Type (2011-2016)
  • 3.2 United States Bevacizumab Revenue and Market Share by Type (2011-2016)
  • 3.3 United States Bevacizumab Price by Type (2011-2016)
  • 3.4 United States Bevacizumab Sales Growth Rate by Type (2011-2016)
  • 4 United States Bevacizumab Sales (Volume) by Application (2011-2016)
  • 4.1 United States Bevacizumab Sales and Market Share by Application (2011-2016)
  • 4.2 United States Bevacizumab Sales Growth Rate by Application (2011-2016)
  • 4.3 Market Drivers and Opportunities
  • 5 United States Bevacizumab Manufacturers Profiles/Analysis
  • 5.1 Pfizer
  • 5.1.1 Company Basic Information, Manufacturing Base and Competitors
  • 5.1.2 Bevacizumab Product Type, Application and Specification
  • 5.1.2.1 Type I
  • 5.1.2.2 Type II
  • 5.1.3 Pfizer Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.1.4 Main Business/Business Overview
  • 5.2 Biocon
  • 5.2.2 Bevacizumab Product Type, Application and Specification
  • 5.2.2.1 Type I
  • 5.2.2.2 Type II
  • 5.2.3 Biocon Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.2.4 Main Business/Business Overview
  • 5.3 Bionomics
  • 5.3.2 Bevacizumab Product Type, Application and Specification
  • 5.3.2.1 Type I
  • 5.3.2.2 Type II
  • 5.3.3 Bionomics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.3.4 Main Business/Business Overview
  • 5.4 Amgen
  • 5.4.2 Bevacizumab Product Type, Application and Specification
  • 5.4.2.1 Type I
  • 5.4.2.2 Type II
  • 5.4.3 Amgen Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.4.4 Main Business/Business Overview
  • 5.5 Genexine
  • 5.5.2 Bevacizumab Product Type, Application and Specification
  • 5.5.2.1 Type I
  • 5.5.2.2 Type II
  • 5.5.3 Genexine Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.5.4 Main Business/Business Overview
  • 5.6 Levolta Pharmaceuticals
  • 5.6.2 Bevacizumab Product Type, Application and Specification
  • 5.6.2.1 Type I
  • 5.6.2.2 Type II
  • 5.6.3 Levolta Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.6.4 Main Business/Business Overview
  • 5.7 Enzon Pharmaceuticals
  • 5.7.2 Bevacizumab Product Type, Application and Specification
  • 5.7.2.1 Type I
  • 5.7.2.2 Type II
  • 5.7.3 Enzon Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.7.4 Main Business/Business Overview
  • 5.8 Marsala Biotech
  • 5.8.2 Bevacizumab Product Type, Application and Specification
  • 5.8.2.1 Type I
  • 5.8.2.2 Type II
  • 5.8.3 Marsala Biotech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.8.4 Main Business/Business Overview
  • 5.9 Mabtech
  • 5.9.2 Bevacizumab Product Type, Application and Specification
  • 5.9.2.1 Type I
  • 5.9.2.2 Type II
  • 5.9.3 Mabtech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.9.4 Main Business/Business Overview
  • 5.10 Fujifilm Kyowa Kirin Biologics
  • 5.10.2 Bevacizumab Product Type, Application and Specification
  • 5.10.2.1 Type I
  • 5.10.2.2 Type II
  • 5.10.3 Fujifilm Kyowa Kirin Biologics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.10.4 Main Business/Business Overview
  • 6 Bevacizumab Manufacturing Cost Analysis
  • 6.1 Bevacizumab Key Raw Materials Analysis
  • 6.1.1 Key Raw Materials
  • 6.1.2 Price Trend of Key Raw Materials
  • 6.1.3 Key Suppliers of Raw Materials
  • 6.1.4 Market Concentration Rate of Raw Materials
  • 6.2 Proportion of Manufacturing Cost Structure
  • 6.2.1 Raw Materials
  • 6.2.2 Labor Cost
  • 6.2.3 Manufacturing Expenses
  • 6.3 Manufacturing Process Analysis of Bevacizumab
  • 7 Industrial Chain, Sourcing Strategy and Downstream Buyers
  • 7.1 Bevacizumab Industrial Chain Analysis
  • 7.2 Upstream Raw Materials Sourcing
  • 7.3 Raw Materials Sources of Bevacizumab Major Manufacturers in 2015
  • 7.4 Downstream Buyers
  • 8 Marketing Strategy Analysis, Distributors/Traders
  • 8.1 Marketing Channel
  • 8.1.1 Direct Marketing
  • 8.1.2 Indirect Marketing
  • 8.1.3 Marketing Channel Development Trend
  • 8.2 Market Positioning
  • 8.2.1 Pricing Strategy
  • 8.2.2 Brand Strategy
  • 8.2.3 Target Client
  • 8.3 Distributors/Traders List
  • 9 Market Effect Factors Analysis
  • 9.1 Technology Progress/Risk
  • 9.1.1 Substitutes Threat
  • 9.1.2 Technology Progress in Related Industry
  • 9.2 Consumer Needs/Customer Preference Change
  • 9.3 Economic/Political Environmental Change
  • 10 United States Bevacizumab Market Forecast (2016-2021)
  • 10.1 United States Bevacizumab Sales, Revenue Forecast (2016-2021)
  • 10.2 United States Bevacizumab Sales Forecast by Type (2016-2021)
  • 10.3 United States Bevacizumab Sales Forecast by Application (2016-2021)
  • 10.4 Bevacizumab Price Forecast (2016-2021)
  • 11 Research Findings and Conclusion
  • 12 Appendix
  • Disclosure Section
  • Research Methodology
  • Data Source
  • Disclaimer

Please select a license type

Share

Related Products

QYResearchUnited States Bevacizumab Market Report 2016 Product ThumbnailUnited States Bevacizumab Market Report 2016 , Industry ReportProduct #: 617916
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved